DDF, Immuneering form $1.3m Alzheimer’s research collaboration
Britain’s Dementia Discovery Fund has formed a research collaboration with US group Immuneering Corporation that aims to identify novel drug targets and candidates for Alzheimer’s disease.
Read More
